Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$672M |
| 2 |
Merck
MRK
|
+$608M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$384M |
| 4 |
Las Vegas Sands
LVS
|
+$378M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$303M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ralph Lauren
RL
|
+$518M |
| 2 |
eBay
EBAY
|
+$474M |
| 3 |
Estee Lauder
EL
|
+$435M |
| 4 |
Goldman Sachs
GS
|
+$323M |
| 5 |
TechnipFMC
FTI
|
+$304M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.39% |
| 2 | Consumer Discretionary | 14.31% |
| 3 | Technology | 11.26% |
| 4 | Communication Services | 11.24% |
| 5 | Energy | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$4.19T
| $2.91B | 2.78% |
104,902,372
-3,621,563
| -3% | -$105M |
|
2
Apple
AAPL
$4.67T
| $2.42B | 2.31% |
126,042,224
-8,827,084
| -7% | -$168M |
|
3
Mastercard
MA
$521B
| $2.34B | 2.24% |
31,303,309
-2,661,401
| -8% | -$208M |
|
4
Amazon
AMZN
$2.87T
| $2.02B | 1.93% |
120,155,080
-2,229,220
| -2% | -$41.4M |
|
5
Biogen
BIIB
$32.3B
| $1.94B | 1.85% |
6,337,153
-168,678
| -3% | -$53.5M |
|
6
Meta Platforms (Facebook)
META
$1.47T
| $1.71B | 1.63% |
28,314,947
+4,015,982
| +17% | +$254M |
|
7
Booking.com
BKNG
$155B
| $1.56B | 1.49% |
32,720,600
-6,014,225
| -16% | -$297M |
|
8
Bristol-Myers Squibb
BMY
$136B
| $1.51B | 1.44% |
29,020,312
-819,155
| -3% | -$43.6M |
|
|
MON
9
DELISTED
Monsanto Co
MON
| $1.5B | 1.43% |
13,153,624
-982,965
| -7% | -$109M |
|
10
Nike
NKE
$58.7B
| $1.34B | 1.29% |
36,405,300
+3,889,952
| +12% | +$147M |
|
|
11
Merck
MRK
$366B
| $1.32B | 1.27% |
24,444,102
+11,732,725
| +92% | +$608M |
|
|
AGN
12
DELISTED
Allergan Inc
AGN
| $1.32B | 1.27% |
10,664,005
-63,031
| -0.6% | -$7.67M |
|
13
Visa
V
$712B
| $1.3B | 1.24% |
24,000,984
+709,576
| +3% | +$39.4M |
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.28B | 1.22% |
8,381,170
-16,719
| -0.2% | -$2.66M |
|
15
SLB Ltd
SLB
$85.1B
| $1.24B | 1.18% |
12,680,375
+2,064,989
| +19% | +$187M |
|
16
TJX Companies
TJX
$149B
| $1.23B | 1.18% |
40,563,854
-3,709,314
| -8% | -$112M |
|
|
NVO
17
Novo Nordisk
NVO
$202B
| $1.21B | 1.16% |
53,070,498
+876,458
| +2% | +$18.7M |
|
18
Salesforce
CRM
$211B
| $1.2B | 1.14% |
20,956,125
+147,332
| +0.7% | +$8.81M |
|
19
Boeing
BA
$166B
| $1.15B | 1.1% |
9,186,530
-831,849
| -8% | -$108M |
|
|
CXO
20
DELISTED
CONCHO RESOURCES INC.
CXO
| $1.15B | 1.1% |
9,392,629
+5,381
| +0.1% | +$592K |
|
21
Walt Disney
DIS
$187B
| $1.14B | 1.09% |
14,260,659
-263,187
| -2% | -$20.4M |
|
22
Gilead Sciences
GILD
$181B
| $1.13B | 1.08% |
15,915,758
-313,104
| -2% | -$24.6M |
|
23
Capri Holdings
CPRI
$1.53B
| $1.1B | 1.05% |
11,776,993
-338,725
| -3% | -$30.6M |
|
|
PCP
24
DELISTED
PRECISION CASTPARTS CORP
PCP
| $1.09B | 1.05% |
4,324,353
-26,360
| -0.6% | -$6.82M |
|
25
Illumina
ILMN
$32.6B
| $1.09B | 1.04% |
7,517,192
-1,219,837
| -14% | -$179M |
|
Similar funds
Jennison Associates's Q1 2014 Portfolio in Review
As of Q1 2014, Jennison Associates held 826 positions worth $105B, up 2.6% from $102B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jennison Associates's Q1 2014 filing shows 122 new, 275 increased, 321 reduced and 94 closed positions. Its largest new stake was Perrigo: 4,257,843 shares worth $659M. The largest sale was Ralph Lauren, an estimated $518M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q1 2014 buy was Perrigo: 4,257,843 shares worth $659M.
- Jennison Associates added most to Merck in Q1 2014, an estimated $608M increase.
- Jennison Associates's biggest Q1 2014 reduction was Estee Lauder, cutting an estimated $435M.
- Jennison Associates fully exited Ralph Lauren in Q1 2014, selling an estimated $518M.
- Jennison Associates's ten largest holdings make up 18% of its $105B portfolio in Q1 2014.
- Jennison Associates opened 122 new positions and closed 94 in Q1 2014.
- Jennison Associates's portfolio value rose 2.6% quarter-over-quarter to $105B.
Based on Jennison Associates's 13F filing for Q1 2014, filed 7 May 2014.